Bruce J. Sargent is Sr VP & Drug Discovery at ALBANY MOLECULAR RESEARCH INC (AMRI). They have made 9 open-market trades across 1 company since 2011, most recently 2013-06-02.
CIK 0001512062
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMRI | 55,840 | $1.2M |
Shares reported on the most recent Form 4, priced at the 2013-06-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMRI | SELL | 2013-05-22 | 2013-05-23 | $10.97 | $82K | -12.1% | -2.5% | -2.5% |
| AMRI | SELL | 2013-03-18 | 2013-03-20 | $9.94 | $5K | -12.1% | -2.5% | -2.5% |
| AMRI | SELL | 2013-03-11 | 2013-03-13 | $10.45 | $64K | -12.1% | -2.5% | -2.5% |
| AMRI | SELL | 2013-02-22 | 2013-02-26 | $8.18 | $8K | -12.1% | -2.5% | -2.5% |
| AMRI | SELL | 2012-06-05 | 2012-06-07 | $2.28 | $1K | -12.1% | -2.5% | -2.5% |
| AMRI | SELL | 2012-03-19 | 2012-03-21 | $2.76 | $3K | -12.1% | -2.5% | -2.5% |
| AMRI | SELL | 2012-03-06 | 2012-03-08 | $2.66 | $585 | -12.1% | -2.5% | -2.5% |
| AMRI | SELL | 2011-05-06 | 2011-05-12 | $4.84 | $1K | -12.1% | -2.5% | -2.5% |
| AMRI | SELL | 2011-03-07 | 2011-03-28 | $4.24 | $5K | -12.1% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.